• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office.

作者信息

Burtles S S, Newell D R, Henrar R E, Connors T A

机构信息

Cancer Research Campaign, Cambridge Terrace, London, U.K.

出版信息

Eur J Cancer. 1995;31A(3):408-10. doi: 10.1016/0959-8049(94)00483-l.

DOI:10.1016/0959-8049(94)00483-l
PMID:7786609
Abstract
摘要

相似文献

1
Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office.欧洲新型细胞毒性抗癌药物临床前毒理学通用指南的修订。癌症研究运动（CRC）一期/二期临床试验委员会和欧洲癌症研究与治疗组织（EORTC）新药开发办公室。
Eur J Cancer. 1995;31A(3):408-10. doi: 10.1016/0959-8049(94)00483-l.
2
General guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. Joint Steering Committee of the European Organization for Research and Treatment of Cancer (EORTC) and the Cancer Research Campaign (CRC).
Eur J Cancer. 1990 Mar;26(3):411-4. doi: 10.1016/0277-5379(90)90244-n.
3
Anticancer Drug Development: The Way Forward.抗癌药物研发：前进之路
Oncologist. 1996;1(3):180-181.
4
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.新型癌症治疗药物早期临床试验的仅啮齿动物毒理学评估。
Br J Cancer. 1999 Nov;81(5):760-8. doi: 10.1038/sj.bjc.6690761.
5
Of (only) mice and men.只关乎人与鼠。 （注：这是根据字面意思翻译，此句可能源自文学作品等特定语境，有更丰富含义，比如“人鼠之间”是一部文学作品名，这里按要求仅给出字面翻译）
Br J Cancer. 1999 Nov;81(5):753-5. doi: 10.1038/sj.bjc.6690759.
6
Pharmacologically guided phase I clinical trials based upon preclinical drug development.基于临床前药物研发的药理学指导的I期临床试验。
J Natl Cancer Inst. 1990 Aug 15;82(16):1321-6. doi: 10.1093/jnci/82.16.1321.
7
Predictive value of preclinical toxicology studies for platinum anticancer drugs.铂类抗癌药物临床前毒理学研究的预测价值。
Clin Cancer Res. 1999 May;5(5):1161-7.
8
EORTC guidelines for phase I trials with single agents in adults. EORTC New Drug Development Committee.
Eur J Cancer Clin Oncol. 1985 Sep;21(9):1005-7. doi: 10.1016/0277-5379(85)90282-2.
9
Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer.
Eur J Cancer. 1997 Aug;33(9):1361-3.
10
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.肿瘤学抗体药物偶联物非临床安全性评价的考量因素
Regul Toxicol Pharmacol. 2013 Dec;67(3):382-91. doi: 10.1016/j.yrtph.2013.08.017. Epub 2013 Sep 5.

引用本文的文献

1
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.在小鼠肿瘤模型中，环境温度诱导的应激通过β2-肾上腺素能受体激活导致治疗耐药性。
Nat Commun. 2015 Mar 10;6:6426. doi: 10.1038/ncomms7426.
2
Animal models and conserved processes.动物模型与保守过程。
Theor Biol Med Model. 2012 Sep 10;9:40. doi: 10.1186/1742-4682-9-40.
3
Murine models to evaluate novel and conventional therapeutic strategies for cancer.用于评估癌症新型和传统治疗策略的小鼠模型。
Am J Pathol. 2007 Mar;170(3):793-804. doi: 10.2353/ajpath.2007.060929.
4
Modelling and simulation in the development and use of anti-cancer agents: an underused tool?抗癌药物研发与应用中的建模与模拟：一种未得到充分利用的工具？
J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):419-40. doi: 10.1007/s10928-005-5910-2.
5
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.汤姆·康纳斯教授与英国癌症研究中心I/II期临床试验委员会新型癌症疗法的研发。
Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106.
6
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients.英国癌症研究中心针对癌症患者I期前正电子发射断层扫描研究用放射性示踪剂的生产与毒理学程序。
Br J Cancer. 2002 Apr 8;86(7):1052-6. doi: 10.1038/sj.bjc.6600212.
7
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.新型癌症治疗药物早期临床试验的仅啮齿动物毒理学评估。
Br J Cancer. 1999 Nov;81(5):760-8. doi: 10.1038/sj.bjc.6690761.
8
United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).英国癌症研究协调委员会（UKCCCR）《实验性肿瘤学动物福利指南》（第二版）
Br J Cancer. 1998;77(1):1-10. doi: 10.1038/bjc.1998.1.